You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
3D MEDICINES(01244.HK)擬配售合共215萬股 總籌2.322億港元
格隆匯 07-14 08:20

格隆匯7月14日丨3D MEDICINES(01244.HK)發佈公吿,2023年7月14日(交易時間前),公司與獨家整體協調人及配售代理摩根大通訂立配售協議,據此,配售代理已同意作為公司代理,盡最大努力促使不少於六名承配人,以每股配售股份108.00港元的價格,認購合共215萬股配售股份。

配售股份相當於公司現有已發行股本約0.84%及緊隨配售後經擴大已發行股本約0.83%。配售股份將根據一般授權配發及發行,無需股東額外批准。假設215萬股配售股份獲悉數認購,配售完成後,配售所得款項總額將為2.322億港元,所得款項淨額(扣除所有適用成本及開支(包括佣金(假設酌情佣金已全額支付)及徵費)後)估計為2.262億港元。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account